title: Pompholyx (vesicular eczema) after i.v. immunoglobulin therapy for neurologic disease.
authors.affiliation: Department of Neurology, San Raffaele Scientific Institute, Milan, Italy. iannaccone.sandro@hsr.it
authors.forename: S
authors.initials: S
authors.lastname: Iannaccone
authors.forename: B
authors.initials: B
authors.lastname: Sferrazza
authors.forename: A
authors.initials: A
authors.lastname: Quattrini
authors.forename: S
authors.initials: S
authors.lastname: Smirne
authors.forename: L
authors.initials: L
authors.lastname: Ferini-Strambi
mesh_terms: D000328:Adult; D000368:Aged; D011146:Eczema, Dyshidrotic / Q000139:chemically induced*; D005260:Female; D020275:Guillain-Barre Syndrome / Q000188:drug therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000188:drug therapy*
chemical_list: D016756:Immunoglobulins, Intravenous